LITERATURE REVIEW

 




LITERATURE REVIEW

Crude hypericum oblongifolium extract was studied for its anti-nociceptive, antipyretic and inflammatory properties by Naila Raziq et al[1]. They conducted hot plate tests and in vivo acetic acid-induced writhing experiments to determine the antinociceptive effects of 100,200 and 300mg/kgi.p. Yeast-induced hyperthermia and carrageenan-induced mouse paw edema were used to investigate the anti-inflammatory and anti-pyretic properties of methanol extracts, correspondingly. In numerous animal model, they discovered that methanol extract of hypericum oblongifolium had notable anti-pyretic, antinociceptive and anti-inflammatory properties.

Ghulam Abbas et al[2] investigated the crude extracts of the two medicinally significant herbs hypericum perforatum and hypericum oblongifolium, for their possible cytotoxicity research, anti-lipid peroxidation, anti-glycation and antioxidant. They explore that aqueous n-Butanol fraction of hypericum perforatum demonstrated significant anti-oxidant potential in the 1,I-Diphenyl-2-picrylhydrazylradical (DPPH) assay, with IC value 91.44±2.052 and 119.781±2.821 µg/ml . The n-Butanol fraction of hypericum oblongifolium also demonstrated temperate activity with IC value 215.375±3.562. In their study, inhibitory activities against protein glycation were demonstrated by the n-butanol and n-hexane fractions, respectively, at 57.250% and 50.018%.According to their research, both species, aqueous and n-Butanol fractions exhibit favorable anti-oxidant and anti-glycation capabilities in vitro with no harmful side effects.

Naila Raziq et al[3] studied phytochemicals research on hypericum oblongifolium caused the ethyl acetate fraction of methanolic extract to be used to isolate the flavones folicitin and a bicyclic conjugated lactone called folenolide. Based on thorough spectroscopic research, both metabolites were classified as novel substances by them. They used the 1,I-Diphenyl-2-picrylhydrazylradical (DPPH) assay to asses both drugs in vitro anti-oxidant activity. They found that the compound namely folicitin was active anti-oxidant while folenolide was sedentary.

A comprehensive study done by Shubhangi et al[4] shows that a review of the literature for many papers, journals, and traditional Indian medical materials state that Hypericum oblongifolium contains a lot of therapeutic benefits. It is widely accepted that they have a history of being used to cure conditions including stomach ulcer, snake bite and respiratory disease.  They found in their study that several secondary metabolites from hypericum oblongifolium show numerous medicinal properties like anti-microbial and anti-oxidant.

Using the common writhing test on mice, the analgesic efficacy of the medicinal herb hypericum oblongifolium was examined experimentally by Jamshed Ali et al[5]. According to their research, the plant has anti-inflammatory and analgesic properties, which may be caused by the existence of flavonoids. In their investigation, they did specify that it is important to check furthermore that, if these medicinal herbs has any anti-inflammatory or narcotic properties.

Namdar Yousofvand et al[6] presented a review on hypericum oblongifolium and concluded that this plant contain saponins flavonoids and tannis. Additionally, there are chemicals substances including ramentine, myrcetin, kaempeferol and quecretin. Furthermore, this plant has been linked to reports of peripheral anti-nociceptive and fever and inflammation lowering properties[7].  

Bahare Salehi et al[8] conducted a research on the phytochemiclas that have antidiabetic effects. According to their findings, the phytochemicals that can serve as anti-diabetic agents are phenolic acid, alkaloids, glycosides and flavonoids. They studied various animals studies in which numerous processes are outlined that account for phytochemiclas positive benefits, involving control of glucose metabolism, stimulation of β-cells, Reactive Oxygen Species (ROS) protection, Insulin production and NF-KB signaling pathway. They also presented the idea of treating diabetes mellitus (DM) with readily available plants-based chemicals that do not require complicated pharmaceutical production is quietly appealing.

Goncalo Infant Calderia et al[9] investigated and recorded 58 distinct hypericum plant species as potential for the organic compounds. They further noted the specific cytotoxicity of several hypericum species against inhibition of adipogensis, anti-Alzheimer, anti-microbial, anti-depressent, anti-inflammatory.

1.         Raziq, N., et al., Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia. BMC complementary and alternative medicine, 2015. 16: p. 1-7.

2.         Abba, G., Non-to Inhibit pr.

3.         Raziq, N., et al., In vitro anti-oxidant potential of new metabolites from Hypericum oblongifolium (Guttiferae). Natural Product Research, 2015. 29(24): p. 2265-2270.

4.         Mehra, S. and A.N. Sah, HYPERICUM OBLONGIFOLIUM A REVIEW.

5.         Ali, J., et al., PHARMACOLOGICAL SCREENING OF HYPERICUM OBLONGIFOLIUM FOR ITS ANALGESIC EFFECT IN MICE. Journal of Medical Sciences, 2020. 28(3): p. 260-264.

6.         Yousofvand, N. and B. Moloodi, An overview of the effect of medicinal herbs on pain.     Phytotherapy Research, 2022.

7.         Ferheen, S., et al., Hyperinols A and B, chymotrypsin inhibiting triterpenes from Hypericum oblongifolium. Chemical and pharmaceutical bulletin, 2006. 54(8): p. 1088-1090.

8.         Salehi, B., et al., Ficus plants: state of the art from a phytochemical, pharmacological, and toxicological perspective. Phytotherapy Research, 2021. 35(3): p. 1187-1217.

9.         Caldeira, G.I., et al., Hypericum Genus as a Natural Source for Biologically Active Compounds. Plants, 2022. 11(19): p. 2509. 

Comments

Popular posts from this blog

Undermining justice:The perils of political interference in Pakistan Judicial System

Phonetic transcription

LITERARY TERMS